Document is current
Any future updates will be listed below
-
Authors
Langner, S. Magdalena
Terheyden, Jan H.
Geerling, Clara F.
Kindler, Christine
Keil, Vera C. W.
Turski, Christopher A.
Turski, Gabrielle N.
Behning, Charlotte
Wintergerst, Maximilian W. M. https://orcid.org/0000-0002-2766-7038
Petzold, Gabor C.
Finger, Robert P.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Bonn
- License Information
-
More Information
Article History
Received: 10 November 2021
Accepted: 16 May 2022
First Online: 3 June 2022
Competing interests
: SML, JHT, CFG, CAT, GNT: Heidelberg Engineering, Optos, Carl Zeiss Meditec, CenterVue (devices). CB, CK, VCK: none. MWMW: Heidelberg Engineering, Optos, Carl Zeiss Meditec, CenterVue, D-EYE Srl (devices); DigiSight Technologies (travel support); Heine Optotechnik (research funding, devices, travel reimbursement, consultant); Eyenuk Inc. (free analysis); ASKIN & CO GmbH (travel reimbursement, honoraria); Berlin-Chemie AG (grant, travel reimbursements). GCP: Bayer, Boehringer Ingelheim, Pfizer, BMS (sponsoring). RPF: Bayer, Novartis, Santen, Opthea, Novelion, Santhera, Inositec, Alimera, Retina Implant, Allergan, Boehringer Ingelheim (consultant); Bayer, Ellex, Alimera (research funding); Heidelberg Engineering, Optos, Carl Zeiss Meditec, CenterVue (devices).
